Jazz Pharmaceuticals Cash Flow Statement (2010-2026) | JAZZ

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-364.66M	-49.53M	-32.36M	5.79M	37.11M	-17.13M	-239.95M	70.42M	106.08M	146.72M	94.63M	-13.27M	168.63M	215.34M	191.15M	-92.00M	-718.35M	251.44M	203.51M	293.10M
Depreciation and Depletion (Quarter)	6.83M	7.77M	7.33M	7.62M	7.75M	7.59M	7.34M	7.57M	7.51M	7.67M	7.65M	7.65M	7.81M	7.78M	9.51M	10.40M	11.93M	9.88M	9.43M	9.10M
Share-based Compensation (Quarter)	3.39M	108.72M	53.12M	50.07M	-10.01M	120.37M	-115.00M	56.35M	-8.90M	126.45M	52.94M	61.44M	56.65M	-64.35M	4.00M	67.70M	1.71M	150.87M	70.85M	74.50M
Deferred Taxes (Quarter)	190.70M	-74.99M	-27.39M	-45.34M	-36.98M	-64.56M	-145.38M	-66.06M	-79.33M	-78.92M	-35.90M	-66.39M	-75.18M	-64.40M	-2.35M	-43.80M	-66.45M	-271.41M	-63.31M	-66.20M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)						133.65M	-133.65M				61.01M
Cash from Operations (Quarter)	41.70M	274.06M	177.75M	208.98M	303.04M	417.99M	341.97M	320.71M	296.76M	307.19M	167.34M	267.23M	331.35M	398.75M	398.58M	429.80M	88.84M	474.62M	362.52M	408.20M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)	22.32M	28.05M	26.60M	12.17M	5.57M	14.26M	5.97M	4.77M	5.43M	6.06M	6.12M	5.99M	5.21M	7.68M	3.10M	17.10M	4.81M	5.30M	5.33M	4.70M
Depreciation & Amortization (CF) (Quarter)	6.83M	7.77M	7.33M	7.62M	7.75M	7.59M	7.34M	7.57M	7.51M	7.67M	7.65M	7.65M	7.81M	7.78M	9.51M	10.40M	11.93M	9.88M	9.43M	9.10M
Change in Working Capital
Change in Receivables (Quarter)	16.59M	-6.88M	64.78M	9.72M	24.51M	9.64M	46.27M	-28.46M	-13.98M	18.86M	75.46M	8.44M	-8.72M	22.26M	-0.86M	-66.00M	55.47M	51.00M	65.81M	6.50M
Change in Inventory (Quarter)	7.39M	4.49M	14.97M	24.81M	17.12M	8.53M	-0.82M	6.27M	0.82M	4.93M	1.40M	12.84M	4.75M	9.29M	18.66M	35.60M	26.25M	31.91M	-7.72M	77.80M
Change in Account Payables (Quarter)	-31.98M	-0.14M	37.85M	-27.62M	2.85M	28.96M	-15.41M	34.29M	-26.82M	10.24M	-8.10M	-19.60M	15.45M	-12.79M	-3.13M	19.10M	-12.63M	62.36M	-28.97M	-21.40M
Change in Accured Expenses (Quarter)	42.97M	36.85M	48.82M	-23.24M	-21.19M	62.29M	148.13M	-96.98M	7.18M	13.55M	53.02M	34.68M	-29.27M	51.02M	-95.70M	2.90M	-78.25M	126.28M	-22.91M	12.20M
Change in Taxes (Quarter)	-46.46M	31.01M	-24.70M	16.77M	-21.23M	4.30M	-1.52M	25.41M	20.52M	15.22M	-35.94M	14.86M	3.17M	2.07M	-34.84M	13.00M	46.27M	12.74M	-34.78M	37.40M
Other Working Capital Changes (Quarter)	18.45M	13.37M	48.60M	-23.17M	0.52M	-1.15M	-11.99M	-42.03M	45.42M	33.94M	89.79M	-54.95M	20.07M	34.16M	22.84M	-41.40M	33.19M	6.67M	-27.49M	-51.90M
Investing Activities
Capital Expenditures (Quarter)	0.33M	17.50M	-18.49M	-0.98M	1.31M	19.34M	4.37M	3.82M	9.09M	0.95M	-13.86M	4.09M	9.90M	10.79M	13.29M		0.80M	857.25M	-799.30M	77.20M
Sales of Property, Plant and Equipment (Quarter)																				200.00M
Acquisitions (Quarter)
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)	335.00M						60.00M			20.00M	250.00M	120.00M	80.00M	355.00M	290.00M	310.00M	470.00M	400.00M	180.00M	520.00M
Cash from Investing Activities (Quarter)	-5912.37M	-26.81M	-10.09M	-37.29M	-89.16M	4.60M	-324.38M	-4.82M	-85.74M	-174.30M	101.80M	-271.90M	-257.09M	214.09M	-193.29M	-169.00M	-640.95M	-327.80M	-372.16M	123.10M
Financing Activities
Other financing activities (Quarter)	51.88M	14.82M	18.15M	21.73M	24.87M	21.26M	30.16M	21.23M	10.87M	5.51M	8.85M	0.49M	10.94M	0.02M	9.20M	11.50M	10.44M	0.73M	85.19M	32.90M
Cash from Financing Activities (Quarter)	4,664.04M	-465.18M	-246.61M	-270.81M	10.78M	-289.05M	19.60M	-29.79M	-96.67M	-78.49M	-100.31M	-56.55M	-161.09M	246.43M	-8.28M	-813.50M	-124.49M	-10.83M	75.44M	-78.50M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)	0.51M	-1.69M	-1.39M	-1.49M	-4.22M	-5.45M	4.93M	0.33M	0.03M	-1.02M	1.79M	-1.70M	-0.76M	3.07M	-2.29M	1.70M	4.62M	0.20M	0.03M	-0.40M
Change in Cash (Quarter)	-1206.13M	-219.62M	-80.33M	-100.61M	220.43M	128.09M	42.12M	286.43M	114.39M	53.39M	170.62M	-62.92M	-87.58M	862.33M	194.73M	-551.00M	-671.98M	136.19M	65.83M	452.40M
Free Cash Flow (Quarter)	41.37M	256.56M	196.25M	209.96M	301.73M	398.65M	337.60M	316.89M	287.68M	306.24M	181.20M	263.14M	321.45M	387.96M	385.29M	429.80M	88.04M	-382.63M	1,161.82M	331.00M
Net Cash Flow (Quarter)	-1206.64M	-217.93M	-78.95M	-99.12M	224.65M	133.54M	37.19M	286.10M	114.36M	54.40M	168.83M	-61.23M	-86.82M	859.26M	197.02M	-552.70M	-676.60M	135.99M	65.80M	452.80M

Research Tools

Developers

Jazz Pharmaceuticals Cash Flow Statement (2010-2026) | JAZZ

Research Tools

Developers

Jazz Pharmaceuticals Cash Flow Statement (2010-2026) | JAZZ

Create an account

Sign In

Reset Password